Yes we only have one primary end point, ORR. So chances are pretty good! But as I mentioned before, down side will be a dollar a share. Upside maybe much higher. If results are good it validates the mixed up trial! PPS maybe back to 5. Risk/Reward ratio is on the upside.
Market Data 
Markets 
